Drug‐induced hepatotoxicity

Alimentary Pharmacology & Therapeutics

Volumn 7, Issue 5, 1993, Pages 477-485

  LEE, W M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ALPHA INTERFERON; AMIODARONE; AZATHIOPRINE; CARBAMAZEPINE; COCAINE; CYPROTERONE ACETATE; DAPSONE; DICLOFENAC; DISULFIRAM; ETOPOSIDE; FLUTAMIDE; GLIBENCLAMIDE; HALOTHANE; IMIPRAMINE; ISONIAZID; KETOCONAZOLE; LABETALOL; LISINOPRIL; MEVINOLIN; NICOTINIC ACID; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PARACETAMOL; PENTAMIDINE; PHENYTOIN; PIROXICAM; PROPYLTHIOURACIL; RIFAMPICIN; SULFAMETHOXAZOLE; VALPROIC ACID; ZIDOVUDINE;

HEPATITIS; HUMAN; LIVER CIRRHOSIS; LIVER TOXICITY; REVIEW;

BIOTRANSFORMATION; CYTOCHROME P-450 ENZYME SYSTEM; DRUG SYNERGISM; HEPATITIS, TOXIC; HUMAN; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; PHARMACEUTICAL PREPARATIONS; SUPPORT, NON-U.S. GOV'T;

EID: 0027525472     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.1993.tb00123.x     Document Type: Review

References (92)

1. Toxic and drug‐induced hepatitis
2. Drug metabolism and hepatotoxicity
3. Centrilobular hepatic necrosis and acute renal failure in glue sniffers
4. Acute carbon tetra‐chloride poisoning in 19 patients
5. Amanita poisoning: treatment and the role of liver transplantation
6. Liver transplantation for severe Amanita phalloides poisoning
7. Acetaminophen induced hepatic necrosis. IV. Protective role of glutathione
8. Cysteamine, methionine and penicillamine in the treatment of paracetamol poisoning
9. Intravenous N‐acetylcysteine: the treatment of choice for paracetamol poisoning
10. Efficacy of oral N‐acetylcysteine in the treatment of acetaminophen overdose
11. Improved outcome of paracetamol‐induced fulminant hepatic failure by late administration of acetylcysteine
12. Apparent potentiation of acetaminophen hepatotoxicity by alcohol
13. Acetaminophen toxicity in alcoholics
14. Acetaminophen hepatotoxicity in the alcoholic
15. Failure of physicians to recognize acetaminophen hepatotoxicity in chronic alcoholics
16. Isoniazid associated hepatitis: report of an outbreak
17. Isoniazid‐associated hepatitis deaths: a review of available information
18. Perspective: preventive isoniazid therapy and the liver
19. Isoniazid‐rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction
20. Halothane hepatitis: a model of immune mediated drug hepatotoxicity
21. Severe hypersensitivity to diphenylhydantoin with circulating antibodies to the drug
22. Long‐term hepatic memory for hypersensitivity to nitrofurantoin
23. Hepatitis due to nitrofurantoin
24. Combined nitrofurantoin toxicity to liver and lung
25. Veno‐occlusive disease of the liver and multi‐organ failure after bone marrow transplantation: A cohort study of 355 patients
26. The role of liver biopsies in psoriatic patients receiving long‐term methotrexate treatment
27. Detection of hepatoxicity associated with methotrexate therapy for psoriasis
28. Fatal fulminating liver failure possibly related to amiodarone treatment
29. Early hepatitis during intravenous amiodarone administration
30. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients
31. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf
32. Hepatic toxicity of vitamin A and synthetic retinooids
33. Liver damage caused by therapeutic vitamin A administration: estimate of dose‐related toxicity in 41 cases
34. Fatal hepatitis after herbal tea (letter)
35. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity
36. Hepatoxicity of herbal remedies
37. Acute hepatic failure associated with the use of lowdose sustained‐release niacin
38. Fulminant hepatic failure after ingestion of sustained‐release nicotinic acid
39. Hepatotoxicity associated with sustained‐release niacin
40. Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole‐trimethoprim
41. Hepatitis associated with amoxicillin‐clavulanic acid combination: report of 15 cases
42. Augmentininduced jaundice with a fatal outcome
43. Predisposing factors in hepatitis induced by isoniazid‐rifampin treatment of tuberculosis
44. Rifampicin hepatitis
45. Interaction of ketoconazole with rifampin and isoniazid
46. Dapsone syndrome in Vanatu: a high incidence during multidrug treatment (MDT) of leprosy
47. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin
48. Acetaminophen, isoniazid and hepatic toxicity
49. Hepatic dysfunction accompanying acute cocaine intoxication
50. Hepatotoxicity associated with cocaine abuse
51. Cocaine and the liver
52. Potentiation of cocaine‐mediated hepatotoxicity by acute and chronic ethanol
53. Drug‐induced allergic hepatitis
54. The allopurinol hypersensitivity syndrome
55. Liver failure due to recombinant alpha interferon (letter)
56. Fever hepatitis and acute interstitial nephritis in a patient with rheumatoid arthritis. Concurrent manifestations of azathioprine hypersensitivity
57. Fatal carbamazepine‐associated hepatitis: report of 2 cases
58. Severe hepatocellular dysfunction following cyproterone acetate therapy
59. Severe hepatitis caused by cyproterone acetate
60. Dapsone‐induced liver necrosis
61. Diclofenac hepatitis
62. Fatal liver failure due to disulfiram
63. Fulminant hepatitis associated with disulfiram
64. Fatal liver failure due to disulfiram
65. Etoposide (VP 16–213) induced hepatitis. Report of three cases following standard‐dose treatments
66. Flutamide and hepatitis
67. Acute hepatitis caused by flutamide (letter)
68. A case of acute hepatitis caused by flutamide (letter)
69. Glyburide‐induced hepatitis (letter)
70. Fulminant hepatic failure: presumably contribution by halothane
71. Halothane hepatitis
72. Halothane anaesthesia and liver damage
73. Ketoconazole‐inducer fulminant hepatitis necessitating liver transplantation
74. Labetalol hepatocixity
75. Fulminant hepatitis after lisinopril administration
76. Lovastatin‐inducei hepatitis
77. Norfloxacin‐induced hepatototoxicity (letter)
78. Ofloxacin in miliary tuberculosis
79. Ofloxacin‐indued acute severe hepatitis
80. Pentamidine‐related acute hepatitis during pneumocystosis treatment in acquired immunodeficiency syndrome (letter)
81. Fatal submassive necrosis of the liver associated with piroxicam
82. Propylthiouracil‐induced fatal hepatic necrosis
83. Jaundice caused by rifampicin; 3 cases
84. Rifampicin hepatitis: a clinical and histological study
85. Sulfamethoxazole‐induced hepatic injury
86. Valproic acid
87. Hepatotoxicity to sodium valproate: a review
88. Valproic aid hepatic fatalities: a retrospective review
89. Zidovudine‐induced hepatitis